CIK 0001472091 · Non-accelerated filer<br>Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264231384
- Phone
- 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-23 | BEDU-ADDO FRANK President/CEO | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2020-04-08 | Iliev Ilian Director | Grant or award · Stock Option (Right to Buy) | +4,500 | 4,500 | ||
| 2020-02-21 | Ali-Jackson Kamil Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2020-02-14 | Freitag Gregory Gene Director | Grant or award | +38,400 | $1.30 | $50K | 40,271 |
| 2020-02-14 | SYKES RICHARD Director | Grant or award | +384,615 | $1.30 | $500K | 445,108 |
| 2020-02-14 | Saik Andrew Chief Financial Officer | Grant or award | +38,400 | $1.30 | $50K | 42,549 |
| 2020-02-14 | Glover Steve C Director | Grant or award | +38,400 | $1.30 | $50K | 57,908 |
| 2019-06-28 | Glover Steve C Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2019-06-28 | SYKES RICHARD Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2019-06-28 | LOUGHLIN JAMES J Director | Grant or award · Stock Option (Right To Purchase) | +9,000 | 9,000 | ||
| 2019-06-28 | Freitag Gregory Gene Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2019-06-28 | BEDU-ADDO FRANK President/CEO | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-06-28 | Bloomquist DeLyle W Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2019-06-06 | WOOD LAUREN Chief Medical Officer | Grant or award · Stock Option (Right To Purchase) | +62,715 | 62,715 | ||
| 2019-06-06 | CONN GREGORY Chief Scientific Officer | Grant or award · Stock Option (Right To Purchase) | +40,000 | 40,000 | ||
| 2019-06-06 | Saik Andrew Chief Financial Officer | Grant or award · Stock Option (Right To Purchase) | +62,715 | 62,715 | ||
| 2019-03-15 | Macdonald R. Loch Director | Option exercise | +10,000 | 580,602 | ||
| 2019-03-15 | Macdonald R. Loch Director | Option exercise · Restricted Stock Units | −10,000 | 0 |
Page 6 of 6 · 118 trades